United States Hyperthermia Treatment for Cancer Market Report 2019

Table of Contents

United States Hyperthermia Treatment for Cancer Market Report 2017
1 Hyperthermia Treatment for Cancer Overview
1.1 Product Overview and Scope of Hyperthermia Treatment for Cancer
1.2 Classification of Hyperthermia Treatment for Cancer by Product Category
1.2.1 United States Hyperthermia Treatment for Cancer Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Hyperthermia Treatment for Cancer Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Microwave Hyperthermia Device
1.2.4 Ultrasound Hyperthermia Device
1.2.5 Infrared Therapy Device
1.2.6 Short-wave Therapy Device
1.3 United States Hyperthermia Treatment for Cancer Market by Application/End Users
1.3.1 United States Hyperthermia Treatment for Cancer Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Research Institutes
1.4 United States Hyperthermia Treatment for Cancer Market by Region
1.4.1 United States Hyperthermia Treatment for Cancer Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Hyperthermia Treatment for Cancer Status and Prospect (2012-2022)
1.4.3 Southwest Hyperthermia Treatment for Cancer Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Hyperthermia Treatment for Cancer Status and Prospect (2012-2022)
1.4.5 New England Hyperthermia Treatment for Cancer Status and Prospect (2012-2022)
1.4.6 The South Hyperthermia Treatment for Cancer Status and Prospect (2012-2022)
1.4.7 The Midwest Hyperthermia Treatment for Cancer Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Hyperthermia Treatment for Cancer (2012-2022)
1.5.1 United States Hyperthermia Treatment for Cancer Sales and Growth Rate (2012-2022)
1.5.2 United States Hyperthermia Treatment for Cancer Revenue and Growth Rate (2012-2022)

2 United States Hyperthermia Treatment for Cancer Market Competition by Players/Suppliers
2.1 United States Hyperthermia Treatment for Cancer Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Hyperthermia Treatment for Cancer Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Hyperthermia Treatment for Cancer Average Price by Players/Suppliers (2012-2017)
2.4 United States Hyperthermia Treatment for Cancer Market Competitive Situation and Trends
2.4.1 United States Hyperthermia Treatment for Cancer Market Concentration Rate
2.4.2 United States Hyperthermia Treatment for Cancer Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Hyperthermia Treatment for Cancer Manufacturing Base Distribution, Sales Area, Product Type

3 United States Hyperthermia Treatment for Cancer Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Hyperthermia Treatment for Cancer Sales and Market Share by Region (2012-2017)
3.2 United States Hyperthermia Treatment for Cancer Revenue and Market Share by Region (2012-2017)
3.3 United States Hyperthermia Treatment for Cancer Price by Region (2012-2017)

4 United States Hyperthermia Treatment for Cancer Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Hyperthermia Treatment for Cancer Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Hyperthermia Treatment for Cancer Revenue and Market Share by Type (2012-2017)
4.3 United States Hyperthermia Treatment for Cancer Price by Type (2012-2017)
4.4 United States Hyperthermia Treatment for Cancer Sales Growth Rate by Type (2012-2017)

5 United States Hyperthermia Treatment for Cancer Sales (Volume) by Application (2012-2017)
5.1 United States Hyperthermia Treatment for Cancer Sales and Market Share by Application (2012-2017)
5.2 United States Hyperthermia Treatment for Cancer Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Hyperthermia Treatment for Cancer Players/Suppliers Profiles and Sales Data
6.1 Andromedic Sri
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Hyperthermia Treatment for Cancer Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Andromedic Sri Hyperthermia Treatment for Cancer Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Celsius42 GmbH
6.2.2 Hyperthermia Treatment for Cancer Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Celsius42 GmbH Hyperthermia Treatment for Cancer Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Huahang
6.3.2 Hyperthermia Treatment for Cancer Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Huahang Hyperthermia Treatment for Cancer Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Pyrexar Medical
6.4.2 Hyperthermia Treatment for Cancer Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Pyrexar Medical Hyperthermia Treatment for Cancer Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Perseon Medical
6.5.2 Hyperthermia Treatment for Cancer Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Perseon Medical Hyperthermia Treatment for Cancer Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Omron Corporation
6.6.2 Hyperthermia Treatment for Cancer Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Omron Corporation Hyperthermia Treatment for Cancer Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Sjn AG Yamamoto Vinita
6.7.2 Hyperthermia Treatment for Cancer Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Sjn AG Yamamoto Vinita Hyperthermia Treatment for Cancer Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
...

7 Hyperthermia Treatment for Cancer Manufacturing Cost Analysis
7.1 Hyperthermia Treatment for Cancer Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Hyperthermia Treatment for Cancer

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Hyperthermia Treatment for Cancer Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Hyperthermia Treatment for Cancer Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Hyperthermia Treatment for Cancer Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Hyperthermia Treatment for Cancer Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Hyperthermia Treatment for Cancer Sales Volume Forecast by Type (2017-2022)
11.3 United States Hyperthermia Treatment for Cancer Sales Volume Forecast by Application (2017-2022)
11.4 United States Hyperthermia Treatment for Cancer Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer



List of Tables and Figures

Figure Product Picture of Hyperthermia Treatment for Cancer
Figure United States Hyperthermia Treatment for Cancer Market Size (K Units) by Type (2012-2022)
Figure United States Hyperthermia Treatment for Cancer Sales Volume Market Share by Type (Product Category) in 2016
Figure Microwave Hyperthermia Device Product Picture
Figure Ultrasound Hyperthermia Device Product Picture
Figure Infrared Therapy Device Product Picture
Figure Short-wave Therapy Device Product Picture
Figure United States Hyperthermia Treatment for Cancer Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Hyperthermia Treatment for Cancer by Application in 2016
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Clinics Examples
Table Key Downstream Customer in Clinics
Figure Research Institutes Examples
Table Key Downstream Customer in Research Institutes
Figure United States Hyperthermia Treatment for Cancer Market Size (Million USD) by Region (2012-2022)
Figure The West Hyperthermia Treatment for Cancer Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Hyperthermia Treatment for Cancer Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Hyperthermia Treatment for Cancer Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Hyperthermia Treatment for Cancer Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Hyperthermia Treatment for Cancer Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Hyperthermia Treatment for Cancer Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Hyperthermia Treatment for Cancer Sales (K Units) and Growth Rate (2012-2022)
Figure United States Hyperthermia Treatment for Cancer Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Hyperthermia Treatment for Cancer Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Hyperthermia Treatment for Cancer Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Hyperthermia Treatment for Cancer Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Hyperthermia Treatment for Cancer Sales Share by Players/Suppliers
Figure 2017 United States Hyperthermia Treatment for Cancer Sales Share by Players/Suppliers
Figure United States Hyperthermia Treatment for Cancer Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Hyperthermia Treatment for Cancer Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Hyperthermia Treatment for Cancer Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Hyperthermia Treatment for Cancer Revenue Share by Players/Suppliers
Figure 2017 United States Hyperthermia Treatment for Cancer Revenue Share by Players/Suppliers
Table United States Market Hyperthermia Treatment for Cancer Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Hyperthermia Treatment for Cancer Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Hyperthermia Treatment for Cancer Market Share of Top 3 Players/Suppliers
Figure United States Hyperthermia Treatment for Cancer Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Hyperthermia Treatment for Cancer Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Hyperthermia Treatment for Cancer Product Category
Table United States Hyperthermia Treatment for Cancer Sales (K Units) by Region (2012-2017)
Table United States Hyperthermia Treatment for Cancer Sales Share by Region (2012-2017)
Figure United States Hyperthermia Treatment for Cancer Sales Share by Region (2012-2017)
Figure United States Hyperthermia Treatment for Cancer Sales Market Share by Region in 2016
Table United States Hyperthermia Treatment for Cancer Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Hyperthermia Treatment for Cancer Revenue Share by Region (2012-2017)
Figure United States Hyperthermia Treatment for Cancer Revenue Market Share by Region (2012-2017)
Figure United States Hyperthermia Treatment for Cancer Revenue Market Share by Region in 2016
Table United States Hyperthermia Treatment for Cancer Price (USD/Unit) by Region (2012-2017)
Table United States Hyperthermia Treatment for Cancer Sales (K Units) by Type (2012-2017)
Table United States Hyperthermia Treatment for Cancer Sales Share by Type (2012-2017)
Figure United States Hyperthermia Treatment for Cancer Sales Share by Type (2012-2017)
Figure United States Hyperthermia Treatment for Cancer Sales Market Share by Type in 2016
Table United States Hyperthermia Treatment for Cancer Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Hyperthermia Treatment for Cancer Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Hyperthermia Treatment for Cancer by Type (2012-2017)
Figure Revenue Market Share of Hyperthermia Treatment for Cancer by Type in 2016
Table United States Hyperthermia Treatment for Cancer Price (USD/Unit) by Types (2012-2017)
Figure United States Hyperthermia Treatment for Cancer Sales Growth Rate by Type (2012-2017)
Table United States Hyperthermia Treatment for Cancer Sales (K Units) by Application (2012-2017)
Table United States Hyperthermia Treatment for Cancer Sales Market Share by Application (2012-2017)
Figure United States Hyperthermia Treatment for Cancer Sales Market Share by Application (2012-2017)
Figure United States Hyperthermia Treatment for Cancer Sales Market Share by Application in 2016
Table United States Hyperthermia Treatment for Cancer Sales Growth Rate by Application (2012-2017)
Figure United States Hyperthermia Treatment for Cancer Sales Growth Rate by Application (2012-2017)
Table Andromedic Sri Basic Information List
Table Andromedic Sri Hyperthermia Treatment for Cancer Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Andromedic Sri Hyperthermia Treatment for Cancer Sales Growth Rate (2012-2017)
Figure Andromedic Sri Hyperthermia Treatment for Cancer Sales Market Share in United States (2012-2017)
Figure Andromedic Sri Hyperthermia Treatment for Cancer Revenue Market Share in United States (2012-2017)
Table Celsius42 GmbH Basic Information List
Table Celsius42 GmbH Hyperthermia Treatment for Cancer Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Celsius42 GmbH Hyperthermia Treatment for Cancer Sales Growth Rate (2012-2017)
Figure Celsius42 GmbH Hyperthermia Treatment for Cancer Sales Market Share in United States (2012-2017)
Figure Celsius42 GmbH Hyperthermia Treatment for Cancer Revenue Market Share in United States (2012-2017)
Table Huahang Basic Information List
Table Huahang Hyperthermia Treatment for Cancer Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Huahang Hyperthermia Treatment for Cancer Sales Growth Rate (2012-2017)
Figure Huahang Hyperthermia Treatment for Cancer Sales Market Share in United States (2012-2017)
Figure Huahang Hyperthermia Treatment for Cancer Revenue Market Share in United States (2012-2017)
Table Pyrexar Medical Basic Information List
Table Pyrexar Medical Hyperthermia Treatment for Cancer Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pyrexar Medical Hyperthermia Treatment for Cancer Sales Growth Rate (2012-2017)
Figure Pyrexar Medical Hyperthermia Treatment for Cancer Sales Market Share in United States (2012-2017)
Figure Pyrexar Medical Hyperthermia Treatment for Cancer Revenue Market Share in United States (2012-2017)
Table Perseon Medical Basic Information List
Table Perseon Medical Hyperthermia Treatment for Cancer Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Perseon Medical Hyperthermia Treatment for Cancer Sales Growth Rate (2012-2017)
Figure Perseon Medical Hyperthermia Treatment for Cancer Sales Market Share in United States (2012-2017)
Figure Perseon Medical Hyperthermia Treatment for Cancer Revenue Market Share in United States (2012-2017)
Table Omron Corporation Basic Information List
Table Omron Corporation Hyperthermia Treatment for Cancer Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Omron Corporation Hyperthermia Treatment for Cancer Sales Growth Rate (2012-2017)
Figure Omron Corporation Hyperthermia Treatment for Cancer Sales Market Share in United States (2012-2017)
Figure Omron Corporation Hyperthermia Treatment for Cancer Revenue Market Share in United States (2012-2017)
Table Sjn AG Yamamoto Vinita Basic Information List
Table Sjn AG Yamamoto Vinita Hyperthermia Treatment for Cancer Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sjn AG Yamamoto Vinita Hyperthermia Treatment for Cancer Sales Growth Rate (2012-2017)
Figure Sjn AG Yamamoto Vinita Hyperthermia Treatment for Cancer Sales Market Share in United States (2012-2017)
Figure Sjn AG Yamamoto Vinita Hyperthermia Treatment for Cancer Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Hyperthermia Treatment for Cancer
Figure Manufacturing Process Analysis of Hyperthermia Treatment for Cancer
Figure Hyperthermia Treatment for Cancer Industrial Chain Analysis
Table Raw Materials Sources of Hyperthermia Treatment for Cancer Major Players/Suppliers in 2016
Table Major Buyers of Hyperthermia Treatment for Cancer
Table Distributors/Traders List
Figure United States Hyperthermia Treatment for Cancer Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Hyperthermia Treatment for Cancer Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Hyperthermia Treatment for Cancer Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Hyperthermia Treatment for Cancer Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Hyperthermia Treatment for Cancer Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Hyperthermia Treatment for Cancer Sales Volume (K Units) Forecast by Type in 2022
Table United States Hyperthermia Treatment for Cancer Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Hyperthermia Treatment for Cancer Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Hyperthermia Treatment for Cancer Sales Volume (K Units) Forecast by Application in 2022
Table United States Hyperthermia Treatment for Cancer Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Hyperthermia Treatment for Cancer Sales Volume Share Forecast by Region (2017-2022)
Figure United States Hyperthermia Treatment for Cancer Sales Volume Share Forecast by Region (2017-2022)
Figure United States Hyperthermia Treatment for Cancer Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources